ArticleCurrent oncology (Toronto, Ont.)2021

Preferences of Canadian Patients and Physicians for Treatment of HR+/HER2- Advanced Breast Cancer.

Daniel Stellato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.